ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

NCI Proposes Extension Of Breast Cancer Screening To Determine Efficacy Of Biennial Tests

November 7, 1975

Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday

July 6, 2012

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Pancreatic Cancer Treatment Shows Postive Early Results

December 30, 2005